About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
Home
About Us
Overview
Leadership
Scientific Advisory Board
Technology
Overview
Transpo-mAb™
SMAC-Technology™
PNU anthracycline payload
Immune Oncology
Publications
Pipeline
News & Events
News
NBE Therapeutics in the News
Events
Contact
Join Our Team
News
NBE Therapeutics in the News
Events
News
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
Select a year
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
November 15 - Dr. Anthony Tolcher joins the Scientific Advisory Board of NBE-Therapeutics
Read more
June 28 - Novo Holdings A/S invests CHF 20 million in a seriesB extension financing of NBE-Therapeutics
Read more
March 5 - USPTO grants US patent for NBE-Therapeutics' core conjugation technology
Read more